Technical Principles and Experimental Applications of In Vivo Macrophage Depletion Agents

Inflammation and Immunology Research: In sepsis, arthritis or neuroinflammation models, macrophage depletion verifies their functions in disease initiation and progression. Comparisons of inflammatory factor levels and pathological scores between depletion and control groups clarify the pathogenic or protective roles of macrophages.

Tumor Microenvironment Research: Tumor‑associated macrophages (TAMs) often exhibit an immunosuppressive phenotype that promotes tumor progression. Observing changes in tumor growth rate, angiogenesis and T‑cell infiltration after TAM depletion evaluates the contribution of macrophages to tumor immune escape.

Infectious Disease Models: In intracellular bacterial infection models such as tuberculosis and leishmaniasis, macrophage depletion directly validates host cell defense functions. Changes in pathogen load post‑depletion reveal whether macrophages inhibit or promote pathogen replication.

Tissue Repair and Fibrosis: In liver and pulmonary fibrosis models, macrophage depletion investigates their dual roles in extracellular matrix deposition and degradation. Dynamic depletion strategies distinguish functional differences of macrophages at different repair stages.

Macrophage Reconstitution Research: Following endogenous macrophage depletion, genetically engineered or subtype‑specific macrophages are transplanted to study their in‑vivo functions, providing preclinical data for cell therapy.

Intraperitoneal Injection: The most commonly‑used route with simple operation and minimal animal stress. Post‑injection liposomes mainly distribute in peritoneal organs (e.g., spleen, liver, peritoneal macrophages), with limited systemic depletion effects. Standard dosage is 200 μL per mouse.

Intravenous Injection: Enables systemic depletion, suitable for studying macrophages in highly vascularized organs including spleen, liver and lung. Liposomes rapidly enter the bloodstream and are captured by the mononuclear phagocyte system. This technique requires skilled operation and causes mild animal damage.

Subcutaneous Injection: Depletes macrophages in local skin and draining lymph nodes, suitable for studying skin inflammation or immune responses at vaccination sites. Injection dosage is adjusted according to volume.

Intranasal Injection: Specifically depletes respiratory macrophages for respiratory disease models such as asthma and pneumonia. Injection volume is generally limited to ≤50 μL to avoid suffocation risk.

Local Injection: Direct injection into specific organs such as testis and brain achieves region‑specific depletion. This method demands precise positioning but yields ideal local depletion effects.

Pre‑injection Preparation: Remove the reagent from 2‑8 °C storage and equilibrate to room temperature (≤30 °C). Gently invert 8‑10 times for mixing; avoid vortex‑induced foaming that damages liposome structures. Load a 1 mL syringe with a 26G needle; use separate syringes for experimental and control groups.

Animal Restraint and Injection Angle: Restrain the mouse’s head and limbs with the left hand, tilt the mouse 30‑45° head‑down to shift peritoneal organs away from the injection site. Insert the needle obliquely at 30° from the lower right abdomen to avoid visceral injury. Aspirate to confirm no blood or intestinal fluid before slow injection of 200 μL liposomes.

Post‑injection Handling: Slowly withdraw the needle and press the injection site gently to prevent fluid leakage. Return mice to cages for recovery and observe for 30 minutes for adverse reactions. Record injection time and dosage for detailed experimental documentation.

Control Setup: A PBS‑liposome control group is mandatory to exclude non‑specific macrophage activation by liposomes. Inject an equal volume of PBS liposomes simultaneously to ensure experimental comparability.

Strict Storage Conditions: Store at 2‑8 °C with a 6‑month shelf life. Freezing or exposure to high temperature (>30 °C) is strictly prohibited, as it disrupts liposome structures. Avoid contact with organic solvents including chloroform, methanol and ethanol.

Fresh‑for‑use Principle: Use equilibrated liposomes immediately; do not keep at room temperature for more than 2 hours. Prolonged standing causes liposome precipitation; invert 6 times for re‑mixing before use.

Dosage Optimization: The standard dosage of 200 μL per mouse applies to most experiments, yet depletion efficiency is affected by mouse weight, strain and baseline macrophage levels. Optimize dosage by detecting F4/80⁺CD11b⁺ macrophage proportions via flow cytometry.

Depletion Kinetics Consideration: Depletion peaks at 24 hours post‑injection and lasts for approximately 5‑7 days. Multiple injections may be required to maintain depletion for long‑term studies, yet frequent injections may induce non‑specific inflammation requiring risk‑benefit evaluation.

Flow Cytometry Detection: Prepare single‑cell suspensions from target organs and quantify macrophage proportion changes via staining for markers such as F4/80, CD11b and CD68. Effective depletion requires ≥80% reduction compared with the control group.

Immunohistochemical Analysis: Perform F4/80 immunohistochemical staining on tissue sections and observe macrophage quantity changes in specific regions (e.g., splenic red pulp) under microscopy. Image analysis software quantifies depletion efficiency.

Functional Verification: Detect post‑depletion cytokine expression levels, pathogen load or pathological alterations in target organs to assess whether biological effects match expectations.

Safety Monitoring: Regularly monitor mouse body weight, activity status and pathological changes in vital organs to ensure no severe toxicity induced by depletion reagents.

【Disclaimer】This article is derived from publicly available online information and generated by AI. If it inadvertently infringes on rights, please contact us promptly, and we will cooperate with the processing immediately without assuming any legal liability.